17-63477132-TGCTGCC-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000789.4(ACE):c.50_55delCGCTGC(p.Pro17_Leu18del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,420,512 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000789.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACE | NM_000789.4 | c.50_55delCGCTGC | p.Pro17_Leu18del | disruptive_inframe_deletion | Exon 1 of 25 | ENST00000290866.10 | NP_000780.1 | |
ACE | NM_001382700.1 | c.-186_-181delCGCTGC | 5_prime_UTR_variant | Exon 1 of 22 | NP_001369629.1 | |||
ACE | NM_001382701.1 | c.-565_-560delCGCTGC | 5_prime_UTR_variant | Exon 1 of 23 | NP_001369630.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000464 AC: 7AN: 150976Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000575 AC: 4AN: 69620Hom.: 0 AF XY: 0.0000744 AC XY: 3AN XY: 40330
GnomAD4 exome AF: 0.0000362 AC: 46AN: 1269426Hom.: 0 AF XY: 0.0000480 AC XY: 30AN XY: 624926
GnomAD4 genome AF: 0.0000463 AC: 7AN: 151086Hom.: 0 Cov.: 31 AF XY: 0.0000406 AC XY: 3AN XY: 73854
ClinVar
Submissions by phenotype
Microvascular complications of diabetes, susceptibility to, 3;C3281105:Hemorrhage, intracerebral, susceptibility to;C5681536:Renal tubular dysgenesis of genetic origin Uncertain:1
- -
not provided Uncertain:1
This variant, c.50_55del, results in the deletion of 2 amino acid(s) of the ACE protein (p.Pro17_Leu18del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs767132000, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ACE-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at